{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:39:59Z","timestamp":1789846799585,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Activation of the tryptophan degrading enzyme indoleamine-2,3-dioxygenase 1 (IDO1) is associated with the development of behavioral signs of depression. Systemic immune challenge induces IDO1 in both the periphery and the brain, leading to increased circulating and brain concentrations of kynurenines. However, whether IDO1 activity within the brain is necessary for the manifestation of depression-like behavior of mice following a central immune challenge remains to be elucidated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We investigated the role of brain IDO1 in mediating depression-like behavior of mice in response to intracerebroventricular injection of saline or lipopolysaccharide (LPS, 10\u00a0ng).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>LPS increased the duration of immobility in the tail suspension test and decreased preference for a sucrose solution. These effects were associated with an activation of central but not peripheral IDO1, as LPS increased brain kynurenine but had no effect on plasma concentrations of kynurenine. Interestingly, genetic deletion or pharmacological inhibition of IDO1, using 1-methyl-tryptophan, abrogated the reduction in sucrose preference induced by intracerebroventricular LPS. 1-Methyl-tryptophan also blocked the LPS-induced increase in duration of immobility during the tail suspension test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These data indicate that activation of brain IDO1 is sufficient to induce depression-like behaviors of mice in response to central LPS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-2094-10-87","type":"journal-article","created":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T08:15:41Z","timestamp":1374135341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors"],"prefix":"10.1186","volume":"10","author":[{"given":"Marcus A","family":"Lawson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M","family":"Parrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H","family":"McCusker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dantzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith W","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"issue":"9","key":"875_CR1","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL: Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. \n                           Biol Psychiatry 2009,65(9):732\u2013741.","journal-title":"Biol Psychiatry"},{"issue":"11","key":"875_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1006\/cyto.1997.0238","volume":"9","author":"M Maes","year":"1997","unstructured":"Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H: Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. \n                           Cytokine 1997,9(11):853\u2013858.","journal-title":"Cytokine"},{"issue":"2","key":"875_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J: Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. \n                           Psychosom Med 2009,71(2):171\u2013186.","journal-title":"Psychosom Med"},{"issue":"5","key":"875_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","volume":"58","author":"A Reichenberg","year":"2001","unstructured":"Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T: Cytokine-associated emotional and cognitive disturbances in humans. \n                           Arch Gen Psychiatry 2001,58(5):445\u2013452.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"875_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.bbi.2005.04.010","volume":"19","author":"KS Krabbe","year":"2005","unstructured":"Krabbe KS, Reichenberg A, Yirmiya R, Smed A, Pedersen BK, Bruunsgaard H: Low-dose endotoxemia and human neuropsychological functions. \n                           Brain Behav Immun 2005,19(5):453\u2013460.","journal-title":"Brain Behav Immun"},{"issue":"1\u20132","key":"875_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(95)01415-2","volume":"711","author":"R Yirmiya","year":"1996","unstructured":"Yirmiya R: Endotoxin produces a depressive-like episode in rats. \n                           Brain Res 1996,711(1\u20132):163\u2013174.","journal-title":"Brain Res"},{"issue":"5","key":"875_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O'Connor","year":"2009","unstructured":"O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R: Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. \n                           Mol Psychiatry 2009,14(5):511\u2013522.","journal-title":"Mol Psychiatry"},{"issue":"11","key":"875_CR8","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/1352458511417835","volume":"17","author":"A Feinstein","year":"2011","unstructured":"Feinstein A: Multiple sclerosis and depression. \n                           Mult Scler 2011,17(11):1276\u20131281.","journal-title":"Mult Scler"},{"issue":"2","key":"875_CR9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.31887\/DCNS.2007.9.2\/arosenblatt","volume":"9","author":"A Rosenblatt","year":"2007","unstructured":"Rosenblatt A: Neuropsychiatry of Huntington's disease. \n                           Dialogues Clin Neurosci 2007,9(2):191\u2013197.","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"875_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","volume":"8","author":"D Aarsland","year":"2012","unstructured":"Aarsland D, Pahlhagen S, Ballard CG, Ehrt U, Svenningsson P: Depression in Parkinson disease\u2013epidemiology, mechanisms and management. \n                           Nat Rev Neurol 2012,8(1):35\u201347.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"875_CR11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-2010-100390","volume":"23","author":"S Aznar","year":"2011","unstructured":"Aznar S, Knudsen GM: Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade? \n                           J Alzheimers Dis 2011,23(2):177\u2013193.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"875_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW: From inflammation to sickness and depression: when the immune system subjugates the brain. \n                           Nat Rev Neurosci 2008,9(1):46\u201356.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"875_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3940(95)12252-4","volume":"203","author":"AJ Cunningham","year":"1996","unstructured":"Cunningham AJ, Murray CA, O'Neill LA, Lynch MA, O'Connor JJ: Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. \n                           Neurosci Lett 1996,203(1):17\u201320.","journal-title":"Neurosci Lett"},{"issue":"4","key":"875_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1469-445X.1999.01892.x","volume":"84","author":"JJ O'Connor","year":"1999","unstructured":"O'Connor JJ, Coogan AN: Actions of the pro-inflammatory cytokine IL-1 beta on central synaptic transmission. \n                           Exp Physiol 1999,84(4):601\u2013614.","journal-title":"Exp Physiol"},{"issue":"1","key":"875_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2006.12.019","volume":"1136","author":"D Cumiskey","year":"2007","unstructured":"Cumiskey D, Butler MP, Moynagh PN, O'Connor J: Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor-alpha on long-term potentiation. \n                           Brain Res 2007,1136(1):13\u201319.","journal-title":"Brain Res"},{"issue":"3","key":"875_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","volume":"36","author":"R Dantzer","year":"2011","unstructured":"Dantzer R, O'Connor JC, Lawson MA, Kelley KW: Inflammation-associated depression: from serotonin to kynurenine. \n                           Psychoneuroendocrinology 2011,36(3):426\u2013436.","journal-title":"Psychoneuroendocrinology"},{"key":"875_CR17","first-page":"431","volume":"7","author":"DM Christmas","year":"2011","unstructured":"Christmas DM, Potokar J, Davies SJ: A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase. \n                           Neuropsychiatr Dis Treat 2011, 7:431\u2013439.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"8","key":"875_CR18","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","volume":"279","author":"AM Myint","year":"2012","unstructured":"Myint AM: Kynurenines: from the perspective of major psychiatric disorders. \n                           FEBS J 2012,279(8):1375\u20131385.","journal-title":"FEBS J"},{"issue":"7","key":"875_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ: Kynurenines in the mammalian brain: when physiology meets pathology. \n                           Nat Rev Neurosci 2012,13(7):465\u2013477.","journal-title":"Nat Rev Neurosci"},{"issue":"13","key":"875_CR20","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1523\/JNEUROSCI.5032-08.2009","volume":"29","author":"JC O'Connor","year":"2009","unstructured":"O'Connor JC, Andre C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, Dantzer R: Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. \n                           J Neurosci 2009,29(13):4200\u20134209.","journal-title":"J Neurosci"},{"issue":"5","key":"875_CR21","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.4049\/jimmunol.0802722","volume":"182","author":"JC O'Connor","year":"2009","unstructured":"O'Connor JC, Lawson MA, Andre C, Briley EM, Szegedi SS, Lestage J, Castanon N, Herkenham M, Dantzer R, Kelley KW: Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. \n                           J Immunol 2009,182(5):3202\u20133212.","journal-title":"J Immunol"},{"issue":"3","key":"875_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.yhbeh.2012.03.010","volume":"62","author":"A Salazar","year":"2012","unstructured":"Salazar A, Gonzalez-Rivera BL, Redus L, Parrott JM, O'Connor JC: Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. \n                           Horm Behav 2012,62(3):202\u2013209.","journal-title":"Horm Behav"},{"issue":"4","key":"875_CR23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3233\/JAD-2011-111097","volume":"28","author":"N Dobos","year":"2012","unstructured":"Dobos N, de Vries EF, Kema IP, Patas K, Prins M, Nijholt IM, Dierckx RA, Korf J, den Boer JA, Luiten PG, Eisel UL: The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. \n                           J Alzheimers Dis 2012,28(4):905\u2013915.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"875_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.neuropharm.2011.08.018","volume":"62","author":"MP Kaster","year":"2012","unstructured":"Kaster MP, Gadotti VM, Calixto JB, Santos AR, Rodrigues AL: Depressive-like behavior induced by tumor necrosis factor-alpha in mice. \n                           Neuropharmacology 2012,62(1):419\u2013426.","journal-title":"Neuropharmacology"},{"issue":"8","key":"875_CR25","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.bbi.2011.05.006","volume":"25","author":"MA Lawson","year":"2011","unstructured":"Lawson MA, Kelley KW, Dantzer R: Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression. \n                           Brain Behav Immun 2011,25(8):1569\u20131575.","journal-title":"Brain Behav Immun"},{"key":"875_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1742-2094-7-43","volume":"7","author":"X Fu","year":"2010","unstructured":"Fu X, Zunich SM, O'Connor JC, Kavelaars A, Dantzer R, Kelley KW: Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. \n                           J Neuroinflammation 2010, 7:43.","journal-title":"J Neuroinflammation"},{"issue":"1\u20132","key":"875_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jneuroim.2003.12.017","volume":"149","author":"JP Godbout","year":"2004","unstructured":"Godbout JP, Berg BM, Kelley KW, Johnson RW: alpha-Tocopherol reduces lipopolysaccharide-induced peroxide radical formation and interleukin-6 secretion in primary murine microglia and in brain. \n                           J Neuroimmunol 2004,149(1\u20132):101\u2013109.","journal-title":"J Neuroimmunol"},{"key":"875_CR28","first-page":"54","volume":"10","author":"MA Lawson","year":"2013","unstructured":"Lawson MA, McCusker RH, Kelley KW: Interleukin-1 beta converting enzyme is necessary for development of depression-like behavior following intracerebroventricular administration of lipopolysaccharide to mice. \n                           J Neuroinflammation 2013, 10:54.","journal-title":"J Neuroinflammation"},{"key":"875_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1742-2094-8-12","volume":"8","author":"SE Park","year":"2011","unstructured":"Park SE, Dantzer R, Kelley KW, McCusker RH: Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. \n                           J Neuroinflammation 2011, 8:12.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"875_CR30","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/nn.2647","volume":"13","author":"EJ Nestler","year":"2010","unstructured":"Nestler EJ, Hyman SE: Animal models of neuropsychiatric disorders. \n                           Nat Neurosci 2010,13(10):1161\u20131169.","journal-title":"Nat Neurosci"},{"key":"875_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1742-2094-8-179","volume":"8","author":"SE Park","year":"2011","unstructured":"Park SE, Lawson M, Dantzer R, Kelley KW, McCusker RH: Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide. \n                           J Neuroinflammation 2011, 8:179.","journal-title":"J Neuroinflammation"},{"issue":"1 Pt 2","key":"875_CR32","first-page":"R125","volume":"266","author":"W Kozak","year":"1994","unstructured":"Kozak W, Conn CA, Kluger MJ: Lipopolysaccharide induces fever and depresses locomotor activity in unrestrained mice. \n                           Am J Physiol 1994,266(1 Pt 2):R125-R135.","journal-title":"Am J Physiol"},{"issue":"8","key":"875_CR33","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.4049\/jimmunol.174.8.4991","volume":"174","author":"JC O'Connor","year":"2005","unstructured":"O'Connor JC, Satpathy A, Hartman ME, Horvath EM, Kelley KW, Dantzer R, Johnson RW, Freund GG: IL-1beta-mediated innate immunity is amplified in the db\/db mouse model of type 2 diabetes. \n                           J Immunol 2005,174(8):4991\u20134997.","journal-title":"J Immunol"},{"key":"875_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bbi.2012.08.008","volume":"31","author":"AW Corona","year":"2013","unstructured":"Corona AW, Norden DM, Skendelas JP, Huang Y, O'Connor JC, Lawson M, Dantzer R, Kelley KW, Godbout JP: Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX3CR1)-deficient mice. \n                           Brain Behav Immun 2013, 31:134\u2013142.","journal-title":"Brain Behav Immun"},{"issue":"11","key":"875_CR35","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00262-012-1265-x","volume":"61","author":"F Qian","year":"2012","unstructured":"Qian F, Liao J, Villella J, Edwards R, Kalinski P, Lele S, Shrikant P, Odunsi K: Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation. \n                           Cancer Immunol Immunother 2012,61(11):2013\u20132020.","journal-title":"Cancer Immunol Immunother"},{"key":"875_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1756-6606-2-8","volume":"2","author":"M Kanai","year":"2009","unstructured":"Kanai M, Funakoshi H, Takahashi H, Hayakawa T, Mizuno S, Matsumoto K, Nakamura T: Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. \n                           Mol Brain 2009, 2:8.","journal-title":"Mol Brain"},{"issue":"15","key":"875_CR37","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.1158\/0008-5472.CAN-07-1872","volume":"67","author":"R Metz","year":"2007","unstructured":"Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC: Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. \n                           Cancer Res 2007,67(15):7082\u20137087.","journal-title":"Cancer Res"},{"issue":"1","key":"875_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00262-008-0513-6","volume":"58","author":"S Lob","year":"2009","unstructured":"Lob S, Konigsrainer A, Zieker D, Brucher BL, Rammensee HG, Opelz G, Terness P: IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. \n                           Cancer Immunol Immunother 2009,58(1):153\u2013157.","journal-title":"Cancer Immunol Immunother"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-10-87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1742-2094-10-87\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-10-87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:19:44Z","timestamp":1630545584000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-10-87"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,18]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["875"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-10-87","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,18]]},"assertion":[{"value":"27 February 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"875"}}